BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pardee AD, Yano H, Weinstein AM, Ponce AA, Ethridge AD, Normolle DP, Vujanovic L, Mizejewski GJ, Watkins SC, Butterfield LH. Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma. J Immunother Cancer 2015;3:32. [PMID: 26199728 DOI: 10.1186/s40425-015-0077-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Nakamoto Y. Promising new strategies for hepatocellular carcinoma. Hepatol Res. 2017;47:251-265. [PMID: 27558453 DOI: 10.1111/hepr.12795] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
2 Ye Z, Li Z, Jin H, Qian Q. Therapeutic Cancer Vaccines. Adv Exp Med Biol 2016;909:139-67. [PMID: 27240458 DOI: 10.1007/978-94-017-7555-7_3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
3 Mizejewski GJ. The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins. Tumor Biol 2016;37:12697-711. [DOI: 10.1007/s13277-016-5131-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Wilson DS, Hirosue S, Raczy MM, Bonilla-Ramirez L, Jeanbart L, Wang R, Kwissa M, Franetich JF, Broggi MAS, Diaceri G, Quaglia-Thermes X, Mazier D, Swartz MA, Hubbell JA. Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity. Nat Mater 2019;18:175-85. [PMID: 30643235 DOI: 10.1038/s41563-018-0256-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 81] [Article Influence: 27.7] [Reference Citation Analysis]
5 Zeng B, Middelberg AP, Gemiarto A, MacDonald K, Baxter AG, Talekar M, Moi D, Tullett KM, Caminschi I, Lahoud MH, Mazzieri R, Dolcetti R, Thomas R. Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy. J Clin Invest 2018;128:1971-84. [PMID: 29485973 DOI: 10.1172/JCI96791] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
6 Wang Y, Yang X, Yu Y, Xu Z, Sun Y, Liu H, Cheng J, Liu M, Sha B, Li L, Ding N, Li Z, Jin H, Qian Q. Immunotherapy of patient with hepatocellular carcinoma using cytotoxic T lymphocytes ex vivo activated with tumor antigen-pulsed dendritic cells. J Cancer 2018;9:275-87. [PMID: 29344274 DOI: 10.7150/jca.22176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
7 Butterfield LH. Lessons learned from cancer vaccine trials and target antigen choice. Cancer Immunol Immunother 2016;65:805-12. [PMID: 26842127 DOI: 10.1007/s00262-016-1801-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang L, Gu X, Yu J, Ge S, Fan X. Oncolytic Virotherapy: From Bench to Bedside. Front Cell Dev Biol 2021;9:790150. [PMID: 34901031 DOI: 10.3389/fcell.2021.790150] [Reference Citation Analysis]
9 Lin B, Wang Q, Liu K, Dong X, Zhu M, Li M. Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer. Front Oncol 2021;11:625936. [PMID: 33718192 DOI: 10.3389/fonc.2021.625936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Qin X, Pan Y, Zhang J, Shen J, Li C. Ionic liquid functionalized trapezoidal Zn-MOF nanosheets integrated with gold nanoparticles for photoelectrochemical immunosensing alpha-fetoprotein. Talanta 2022. [DOI: 10.1016/j.talanta.2022.123684] [Reference Citation Analysis]
11 Rai V, Abdo J, Alsuwaidan AN, Agrawal S, Sharma P, Agrawal DK. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Mol Cell Biochem 2018;437:13-36. [DOI: 10.1007/s11010-017-3092-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
12 Wang X, Wang Q. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.Can J Gastroenterol Hepatol. 2018;2018:9049252. [PMID: 29805966 DOI: 10.1155/2018/9049252] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
13 Li G, Yang L, Li D, Zhang J, Du L, Xia L, Liu Y, Hu W. Effects of combined treatment with PD‑L1 Ig and CD40L mAb on immune tolerance in the CBA/J x DBA/2 mouse model. Mol Med Rep 2020;21:1789-98. [PMID: 32319625 DOI: 10.3892/mmr.2020.10977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]